Venom toxins from Australian elapids

Venom toxins from Australian elapids represent a complex mixture of bioactive proteins and peptides that mediate the lethal effects of snakebites from species such as the Taipan, Brown snake, and Tiger snake, as well as other elapids like the Copperhead and Small-eyed snake. These toxins primarily target the neuromuscular junction, causing paralysis through post-synaptic or pre-synaptic blockade, and the coagulation cascade, leading to venom-induced consumption coagulopathy (VICC) (Isbister & Bawaskar, 2014). Key molecular families involved include phospholipase A2 (PLA2) enzymes, three-finger toxins (3FTx), and prothrombin activators (CSL Antivenom Handbook). In clinical practice, these toxins are the direct targets of antivenom therapy, which utilizes equine-derived antibodies to bind and neutralize the venom components in the bloodstream (White, 2005). The management of envenomation requires rapid identification of the snake group, often facilitated by the Snake Venom Detection Kit (SVDK), to administer the appropriate monovalent or polyvalent antivenom (Isbister, 2010).

Other names

Australian snake venomElapid toxinsAustralian elapid venom proteinsOther Australian elapid venom

Antivenom provides passive immunity by employing venom-specific F(ab')2 or IgG antibody fragments that bind to the circulating toxins. This binding sterically hinders the toxins from interacting with their biological targets, such as nicotinic acetylcholine receptors or coagulation factors, and facilitates their clearance from the systemic circulation (Isbister, 2010; White, 2005).